DEA Increases Registration Fee for Providers Dispensing Controlled Substances

The Drug Enforcement Agency has published a new final rule adjusting the fee schedule for its Diversion Control Program, which includes a more than 30 percent increase in the registration fee assessed to hospitals, clinics physicians, pharmacies and other providers who prescribe or dispense controlled substances.

Advertisement

After the new rate goes into effect of April 16, providers must pay a $731 fee every three years to prescribe or dispense controlled substances. The DEA is authorized under the Controlled Substances Import and Export Act to charge a “reasonable” fee for the registration and control of the manufacture, distribution, dispensing, import and export of controlled substances and listed chemicals, according to the rule.

More Information on Controlled Substances:

AMA, MGMA and Others Release Updated 2011 Guide to E-Prescribing

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.